BioPharma Dive – AI / Data

RA Capital targets China with latest SPAC deal

Published

on

The prominent investor aims to merge its latest special purpose acquisition company with a Chinese biotech, according to a securities filing.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version